Single-dose pharmacokinetic study of lycopene delivered in a well-defined food-based lycopene delivery system (tomato paste-oil mixture) in healthy adult male subjects

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 5, 2004, Pages 850-860

  Gustin, David M ^a   Rodvold, Keith A ^b   Sosman, Jeffery A ^c   Diwadkar Navsariwala, Veda ^b   Stacewicz Sapuntzakis, Maria ^b   Viana, Marlos ^b   Crowell, James A ^d   Murray, Judith ^b   Tiller, Patricia ^b   Bowen, Phyllis E ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHYLOMICRON; LYCOPENE; OIL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; FOOD INTAKE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN EXPERIMENT; LEUKOPENIA; MALE; NAUSEA; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT; SINGLE DRUG DOSE; THROMBOCYTOPENIA; TOMATO;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CAROTENOIDS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHYLOMICRONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; PROBABILITY;

EID: 2942577459     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. I. Epidemiology. Cancer Causes Control 1991;2(5):325-57.
2. Flagg EW, Coates RJ, Greenberg RS. Epidemiologic studies of antioxidants and cancer in humans. J Am Coll Nutr 1995;14(5):419-27.
3. Kushi LH. Vitamin E and heart disease: a case study. Am J Clin Nutr 1999;69(6):1322S-9S.
4. Hininger I, Chopra M, Thurnham DI, et al. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur J Clin Nutr 1997;51(9):601-6.
5. Johnson EJ. The role of carotenoids in human health. Nutr Clin Care 2002;5(2):56-65.
6. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334(18):1150-5.
7. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334(18): 1145-9.
8. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys 1989;274(2):532-8.
9. Khachik F, Carvalho L, Bernstein PS, et al. Chemistry, distribution, and metabolism of tomato carotenoids and their impact on human health. Exp Biol Med (Maywood) 2002;227(10):845-51.
10. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst 1999;91(4):317-31.
11. van het Hof KH, de Boer BC, Tijburg LB, et al. Carotenoid bioavailabiiity in humans from tomatoes processed in different ways determined from the carotenoid response in the triglyceride-rich lipoprotein fraction of plasma after a single consumption and in plasma after four days of consumption. J Nutr 2000;130(5):1189-96.
12. Shi J, Le Maguer M. Lycopene in tomatoes: chemical and physical properties affected by food processing. Crit Rev Biotechnol 2000;20(4):293-334.
13. Bohm V, Bitsch R. Intestinal absorption of lycopene from different matrices and interactions to other carotenoids, the lipid status, and the antioxidant capacity of human plasma. Eur J Nutr 1999;38(3):118-25.
14. Rao AV, Agarwal S. Bioavailability and in vivo antioxidant properties of lycopene from tomato products and their possible role in the prevention of cancer. Nutr Cancer 1998;31(3):199-203.
15. Gartner C, Stahl W, Sies H. Lycopene is more bioavailable from tomato paste than from fresh tomatoes. Am J Clin Nutr 1997;66(1): 116-22.
16. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56(2 Pt 1):35-51.
17. Nguyen ML, Schwartz SJ. Lycopene stability during food processing. Proc Soc Exp Biol Med 1998;218(2):101-5.
18. Clark RM, Yao L, She L, Furr HC. A comparison of lycopene and astaxanthin absorption from com oil and olive oil emulsions. Lipids 2000;35(7):803-6.
19. Livny O, Kaplan I, Reifen R, et al. Lycopene inhibits proliferation and enhances gap-junction communication of KB-1 human oral tumor cells. J Nutr 2002;132(12):3754-9.
20. Heber D, Lu QY. Overview of mechanisms of action of lycopene. Exp Biol Med (Maywood) 2002;227(10):920-3.
21. Levy J, Bosin E, Feldman B, et al. Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr Cancer 1995;24(3):257-66.
22. Karas M, Amir H, Fishman D, et al. Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr Cancer 2000;36(1):101-11.
23. Jewell C, O'Brien NM. Effect of dietary supplementation with carotenoids on xenobiotic metabolizing enzymes in the liver, lung, kidney and small intestine of the rat. Br J Nutr 1999;81(3):235-42.
24. Bhuvaneswari V, Velmurugan B, Nagini S. Induction of glutathione-dependent hepatic biotransformation enzymes by lycopene in the hamster cheek pouch carcinogenesis model. J Biochem Mol Biol Biophys 2002;6(4):257-60.
25. Kotake-Nara E, Kushiro M, Zhang H, et al. Carotenoids affect proliferation of human prostate cancer cells. J Nutr 2001;131(12):3303-6.
26. Kucuk O, Sarkar FH, Djuric Z, et al. Effects of lycopene supplementation in patients with localized prostate cancer. Exp Biol Med (Maywood) 2002;227(10):881-5.
27. Richelle M, Bortlik K, Liardet S, et al. A food-based formulation provides lycopene with the same bioavailability to humans as that from tomato paste. J Nutr 2002;132(3):404-8.
28. Paetau I, Rao D, Wiley ER, et al. Carotenoids in human buccal mucosa cells after 4 wk of supplementation with tomato juice or lycopene supplements. Am J Clin Nutr 1999;70(4):490-4.
29. Johnson EJ. Human studies on bioavailability and plasma response of lycopene. Proc Soc Exp Biol Med 1998;218(2):115-20.
30. Holloway DE, Yang M, Paganga G, et al. Isomerization of dietary lycopene during assimilation and transport in plasma. Free Radic Res 2000;32(1):93-102.
31. Porrini M, Riso P, Testolin G. Absorption of lycopene from single or daily portions of raw and processed tomato. Br J Nutr 1998;80(4): 353-61.
32. Stacewicz-Sapuntzakis M, Bowen PE, Kikendall JW, Burgess M. Simultaneous determination of serum retinol and various carotenoids: their distribution in middle age men and women. J Micronutr Anal 1987;3:27-45.
33. Garg V, Bowen PE, Stacewicz-Sapuntzakis M. Serum lycopene response to daily intake of tomato oleoresin. FASEB J 1995;9:A458.
34. Schreiner R, Stacewicz-Sapuntzakis M, Bowen PE, Sawicki M. Carotenoid analysis of mixed diet aliquots. FASEB J 1992;6:A1657.
35. Borel P, Tyssandier V, Mekki N, et al. Chylomicron β-carotene and retinyl palmitate responses are dramatically diminished when men ingest β-carotene with medium-chain rather than long-chain triglycerides. J Nutr 1998;128(8):1361-7.
36. Dole VP, Hamlin JT 3rd. Particulate fat in lymph and blood. Physiol Rev 1962;42:674-701.
37. Grundy SM, Mok HY. Chylomicron clearance in normal and hyperlipidemic man. Metabolism 1976;25(11):1225-39.
38. Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 2003;43(1):1-18.
39. O'Neill ME, Thurnham DI. Intestinal absorption of β-carotene, lycopene and lutein in men and women following a standard meal: response curves in the triacylglycerol-rich lipoprotein fraction. Br J Nutr 1998;79(2):149-59.
40. Reich P, Shwachman H, Craig JM. Lycopenemia: a variant of carotenemia. N Engl J Med 1960;262:263-9.
41. Kucuk O, Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomark Prev 2001;10(8):861-8.
42. Tabunoki H, Sugiyama H, Tanaka Y, et al. Isolation, characterization, and cDNA sequence of a carotenoid binding protein from the silk gland of Bombyx mori larvae. J Biol Chem 2002;277(35):32133-40.
43. Lakshman MR, Rao MN. Purification and characterization of cellular carotenoid-binding protein from mammalian liver. Methods Enzymol 1999;299:441-56.
44. Erdman JW Jr, Bierer TL, Gugger ET. Absorption and transport of carotenoids. Ann NY Acad Sci 1993;691:76-85.
45. Sugerman SB, Mobarhan S, Bowen PE, et al. Serum time curve characteristics of a fixed dose of β-carotene in young and old men. J Am Coll Nutr 1991;10(4):297-307.
46. Rock CL, Swendseid ME. Plasma β-carotene response in humans after meals supplemented with dietary pectin. Am J Clin Nutr 1992;55(1):96-9.
47. Wingerath T, Stahl W, Sies H. β-Cryptoxanthin selectively increases in human chylomicrons upon ingestion of tangerine concentrate rich in β-cryptoxanthin esters. Arch Biochem Biophys 1995;324(2):385-90.
48. Traber MG, Diamond SR, Lane JC, et al. β-Carotene transport in human lipoproteins. Comparisons with a-tocopherol. Lipids 1994;29(10):665-9.
49. van Vliet T, Schreurs WH, van den Berg H. Intestinal β-carotene absorption and cleavage in men: response of β-carotene and retinyl esters in the triglyceride-rich lipoprotein fraction after a single oral dose of β-carotene. Am J Clin Nutr 1995;62(1):110-6.
50. Brown ED, Micozzi MS, Craft NE, et al. Plasma carotenoids in normal men after a single ingestion of vegetables or purified β-carotene. Am J Clin Nutr 1989;49(6):1258-65.
51. Lin S, Quaroni L, White WS, et al. Localization of carotenoids in plasma low-density lipoproteins studied by surface-enhanced resonance Raman spectroscopy. Biopolymers 2000;57(4):249-56.
52. Lowe GM, Bilton RF, Young AJ, et al. Carotenoid profiles of human plasma lipoproteins. Biochem Soc Trans 1996;24(2):171S.
53. Britton G. Structure and properties of carotenoids in relation to function. FASEB J 1995;9(15):1551-8.